Joint clinical and socio-demographic determinants of CD4 cell count and body weight in HIV/TB co-infected adult patients on HAART

被引:2
|
作者
Birhan, Hailegebrael [1 ]
Seyoum, Awoke [2 ]
Derebe, Kenaw [1 ]
Muche, Setegn [1 ]
Wale, Mitiku [1 ]
Sisay, Solomon [1 ]
机构
[1] Debre Tabor Univ, Coll Nat & Computat Sci, Dept Stat, Debre Tabor, Ethiopia
[2] Bahir Dar Univ, Coll Sci, Dept Stat, Bahir Dar, Ethiopia
关键词
CD4 cell count; HIV; TB co-infection; Joint modeling; Linear mixed model; Weight; TUBERCULOSIS; SURVIVAL; TIME; PREDICTORS; HIV/AIDS; SEPARATE; AFRICA; BURDEN; MODELS;
D O I
10.1016/j.sciaf.2022.e01396
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Tuberculosis is one of the most lethal communicable diseases in the world. In tuberculosis patients, HIV speeds up the course of the infection from latent to active ill-ness. This study aimed to identify joint clinical and socio demographic determinant factors of CD4+ cell count and body weight in HIV/TB co-infected adult patients.Methods: From January 2013 to December 2019, 374 HIV/TB co-infected individuals were treated and had follow-ups. This study used descriptive data analysis, a linear mixed effects model for longitudinal data, and joint modeling of the two longitudinal outcome variables.Results: In this study, 51.1% of the 374 HIV-TB co-infected patients were women, 47.1% were rural dwellers, and 71.9% developed extra pulmonary TB. Females made up 54.3% of all patients who died. To detect the presence of correlation among repeated measured data, the AR (1) structure was chosen. The joint model was more appropriate for analysing and interpreting current data.Conclusions: Baseline age, follow-up time, baseline weight, place of residence, adherence level, educational background, functional status, WHO clinical stage, smoking status and type of TB developed were identified as significant joint factors in CD4 cell count and weight of HIV/TB co-infected patients from potential joint predictor variables. Therefore, the concerned bodies, specifically the FMOH and regional health staffs, should enhance public awareness about the factors that lead to a drop in CD4 count and weight gain, as well as an increased risk of death from HIV/TB co-infection. Furthermore, special attention should be paid to women and patients with poor adherence. Medication and treatment must be affordable and accessible to all co-infected patients in order to maximize their CD4 count and proportional body weight to their height, and to lengthen the lives of indi-viduals who are co-infected. (c) 2022 The Authors. Published by Elsevier B.V. on behalf of African Institute of Mathematical Sciences / Next Einstein Initiative.This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Inverse relationship between the titre of TT virus DNA and the CD4 cell count in patients infected with HIV
    Shibayama, T
    Masuda, C
    Ajisawa, A
    Takahashi, M
    Nishizawa, T
    Tsuda, F
    Okamoto, H
    [J]. AIDS, 2001, 15 (05) : 563 - 570
  • [32] Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count
    Rizzardi, GP
    Tambussi, G
    Bart, PA
    Chapuis, AG
    Lazzarin, A
    Pantaleo, G
    [J]. AIDS, 2000, 14 (15) : 2257 - 2263
  • [33] Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV-Infected Patients: Clinical Implications
    Negredo, Eugenia
    Massanella, Marta
    Puig, Jordi
    Perez-Alvarez, Nuria
    Miguel Gallego-Escuredo, Jose
    Villarroya, Joan
    Villarroya, Francesc
    Molto, Jose
    Ramon Santos, Jose
    Clotet, Bonaventura
    Blanco, Julia
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (09) : 1300 - 1308
  • [34] Association between CD4 Cell Count and Blood Pressure and Its Variation with Body Mass Index Categories in HIV-Infected Patients
    Dimala, Christian Akem
    Kadia, Benjamin Momo
    Kemah, Ben-Lawrence
    Tindong, Maxime
    Choukem, Simeon-Pierre
    [J]. INTERNATIONAL JOURNAL OF HYPERTENSION, 2018, 2018
  • [35] Hepatitis C therapy with interferon-α and ribavirin reduces the CD4 cell count and the total, 2LTR circular and integrated HIV-1 DNA in HIV/HCV co-infected patients
    Jiao, Yan-mei
    Weng, Wen-jia
    Gao, Quan-sheng
    Zhu, Wei-jun
    Cai, Wei-ping
    Li, Ling-hua
    Li, Hong-jun
    Gao, Yan-qing
    Wu, Hao
    [J]. ANTIVIRAL RESEARCH, 2015, 118 : 118 - 122
  • [36] CD4 cell count before chronic hepatitis C (HCV) treatment with direct-acting antivirals (DAAs) and at the end of follow-up in HCV/HIV co-infected patients
    Mendez, Josefina
    Soeiro, Cristina
    Marques, Marta
    Goncalves, Celina
    Tavares, Ana Paula
    Horta, Ana
    Vasconcelos, Olga
    Seabra, Joao
    Abreu, Miguel
    Sarmento e Castro, Rui
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [37] CD4 cell-guided scheduled treatment interruptions in HIV-infected patients with sustained immunologic response to HAART
    Maggiolo, Franco
    Airoldi, Monica
    Callegaro, Annapaola
    Martinelli, Canio
    Dolara, Alberto
    Bini, Teresa
    Gregis, Giampietro
    Quinzan, Giampaolo
    Ripamonti, Diego
    Ravasio, Veronica
    Suter, Fredy
    [J]. AIDS, 2009, 23 (07) : 799 - 807
  • [38] STUDY OF CD4 COUNT IN PRE-ART PERIOD AND DURING ART PERIOD IN SEROPOSITIVE HIV ADULT PATIENTS TO SEE THE EFFECT OF HAART
    Kumar, Brijesh
    Gautam, Shri Krishna
    Anita
    Kumar, Lalit
    Kumar, Pradeep
    Khan, Mohd Imran
    [J]. JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2019, 8 (06): : 381 - 384
  • [39] Comparison of thymic function-related markers to predict early CD4 T-cell repopulation in adult HIV-infected patients on HAART
    Ruiz-Mateos, E
    de la Rosa, R
    Soriano, N
    Martinez-Moya, M
    Rubio, A
    Sánchez-Quijano, A
    Lissen, E
    Leal, M
    [J]. ANTIVIRAL THERAPY, 2003, 8 (04) : 289 - 294
  • [40] CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients
    Read, Sarah W.
    Lempicki, Richard A.
    Di Mascio, Michele
    Srinivasula, Sharat
    Burke, Rosanne
    Sachau, William
    Bosche, Marjorie
    Adelsberger, Joseph W.
    Sereti, Irini
    Davey, Richard T., Jr.
    Tavel, Jorge A.
    Huang, Chiung-Yu
    Issaq, Haleem J.
    Fox, Stephen D.
    Lane, H. Clifford
    Kovacs, Joseph A.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (06): : 843 - 850